High materiality7/10
Insmed price target raised to $175 from $160 at Jefferies
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Jefferies raises INSM target to $175; price $132.55. Upside potential improves.
- Jefferies raises INSM target to $175 (from $160).
- Current price $132.55.
Key facts
- 01
Target: $175
- 02
Posted price: $132.55
- 03
Analyst firm: Jefferies
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.